The research in miRNA for cancer has witnessed a stupendous growth, owing to its property of being an active player in significant human oncogenic signaling pathways. A new research report on “Global miRNA Market Outlook” by RNCOS says that miRNA expression profiles have also been shown to change during treatment with gemcitabine, and the modulation of some miRNAs increases the sensitivity of olangiocarcinoma tumor cells to this chemotherapeutic agent in vitro. Such results offer the experimental basis for the use of miRNAs as therapeutic targets.
The need and demand for having new methods of treating diseases have continued to witness a rapid growth in the last few years, owing to finding the optimal therapies. According to the report,miRNA research has gained a huge momentum in the recent years. The promising miRNA research has provided the researchers with a new vision into various diseases like cancer and diabetes. There has been huge funding to promote the miRNA research for bringing out a new promising method for the treatment and diagnosis of various diseases.
The 60-page report by RNCOS provides an in-depth research and rational analysis of the status of the ongoing miRNA researches across the globe. It presents the detailed description of the role of miRNAs in understanding and treating various diseases, such as cancer, cardiovascular disorders, metabolic disorders and muscle disorders. An analysis of various miRNA techniques prevalent in the market has also been included in the report to provide a balanced outlook on the potentials of miRNAs.
Some of our Related Reports are:
- Booming Biotech Market in India
- Global Gene Therapy Market Analysis
- Global Protein Therapeutics Market Analysis
- Global Biosimilars Market Analysis
- Asia Pacific Biotechnology Market (2008-2012)
|
